Messenger ribonucleic acid vaccine-associated immune thrombocytopenia: A rare complication of vaccine

0Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Coronavirus disease-2019 continues to have a serious impact in countries with the effect of new variant viruses emerging with mutations. While the effectiveness and protection of the vaccine have been determined all over the world, some vaccine-related side effects can be detected in the form of cases. In our case, the patient was admitted to the emergency department of our hospital with complaints of weakness and progressive rash on his legs. Diffuse petechiae purpura on the legs of the patient was observed and complete blood count revealed thrombocytopenia. Peripheral blood smear supported the blood count test results with thrombocytopenia, secondary causes of thrombocytopenia were excluded, and the patient was diagnosed with vaccine-induced immune thrombocytopenia.

Cite

CITATION STYLE

APA

Islamoglu, M. S., Dokur, M., Uysal, B. B., & Gunduz, M. (2022). Messenger ribonucleic acid vaccine-associated immune thrombocytopenia: A rare complication of vaccine. Turkish Journal of Emergency Medicine, 22(2), 111–113. https://doi.org/10.4103/2452-2473.342810

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free